Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | 1 | — | — | 2 |
Triple negative breast neoplasms | D064726 | — | — | 1 | — | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | — | 1 | 1 |
Cytomegalovirus retinitis | D017726 | EFO_1001302 | — | — | — | — | — | 1 | 1 |
Retinitis | D012173 | — | H30.9 | — | — | — | — | 1 | 1 |
Drug common name | Cilmostim |
INN | cilmostim |
Description | Cilmostim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108239 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | EWL6971ETP (ChemIDplus, GSRS) |